SK Bioscience announced on the 22nd that it participated in the foreign student recruitment fair, '2023 Global Talent Fair,' organized by the Ministry of Education and the Ministry of Trade, Industry and Energy, and hosted by the Korea Trade-Investment Promotion Agency (KOTRA) to secure overseas professional talent. Held at COEX in Gangnam-gu, Seoul, this Global Talent Fair is the largest foreign student recruitment fair in Korea, and this year marked its 15th event, attracting a total of 400 companies from both domestic and international markets.


At the Global Talent Fair for international students held at COEX on the 21st, participants visited the SK Bioscience booth to receive explanations. <br>[Photo by SK Bioscience]

At the Global Talent Fair for international students held at COEX on the 21st, participants visited the SK Bioscience booth to receive explanations.
[Photo by SK Bioscience]

View original image

To secure global talent, SK Bioscience actively conducted recruitment activities targeting foreign students at the event. In particular, they held a separate session to explain the company’s global expansion strategy and recruitment process, and a senior employee from Tajikistan working in the overseas business department gave direct advice on employment, drawing enthusiastic responses from attendees with a realistic perspective.


SK Bioscience is currently recruiting outstanding global talent in various fields such as research and development (R&D) and overseas business in line with its future growth strategy, and is actively pursuing talent acquisition this year as well. Last year and earlier this year, the company also consecutively recruited senior executives from international organizations and global big pharma companies. Through this, SK Bioscience plans to expand the global network built during the pandemic period and actively expand its overseas business. Recently, SK Bioscience acquired shares in the U.S. biotech company Novavax to expand strategic cooperation and is working on establishing new pipelines with overseas companies and organizations. Earlier this year, it also established its U.S. subsidiary, ‘SK Bioscience USA,’ to accelerate entry into advanced markets such as the U.S. and Europe.



Jongsu Park, Head of Corporate Culture at SK Bioscience, said, “As our future growth strategy is being implemented concretely, the need to recruit outstanding global talent has grown more than ever before,” adding, “We will actively hire global talent going forward and grow into a world-class company that lives up to our vision as the ‘Global Innovative Partner of Vaccine and Biotech.’”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing